Quarterly report pursuant to Section 13 or 15(d)

Revision of Previously Issued Financial Statements (Tables)

v3.21.1
Revision of Previously Issued Financial Statements (Tables)
3 Months Ended
Mar. 31, 2021
Restatement Of Previously Issued Financial Statements [Abstract]  
Summary of Restatement of Financial Statements
The following tables summarize the effect of the revision on each financial statement line item as of the dates, and for the period, indicated:
 
    
As of March 11, 2021
 
    
As Previously
Reported
   
Adjustment
   
As Corrected
 
Derivative warrant liabilities
   $ —       $ 21,086,630     $ 21,086,630  
Total liabilities
     17,918,408       21,086,630       39,005,038  
Class A common stock, $0.0001 par value; shares subject to possible redemption
     476,540,870       (21,086,630     455,454,240  
Class A common stock, $0.0001 par value
     194       211       405  
Additional paid-in-capital
     5,042,876       634,269       5,677,145  
Accumulated deficit
     (44,314     (634,480     (678,794